EU regulators approve plasma device from Cytomedix

12/12/2012 | MassDevice.com (Boston)

Cytomedix has earned CE mark approval in Europe for use of its Angel concentrated platelet-rich plasma technology with bone marrow aspirate. The system, which was cleared by the FDA last month, includes adjustable settings to allow customized processing and preparation of plasma in clinical settings or at the point of care.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY